METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)

NCT07699380 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes (T1D)
Metabolic Diseases
Glucose Metabolism Disorders
Endocrine System Diseases
Autoimmune Diseases
Immune System Diseases
Diabetes Melletus, Type 1
Nutritional and Metabolic Diseases
Combination Therapy

Interventions

DRUG: AMX0035
DRUG: Placebo

Sponsor

University of Washington

Collaborators

[object Object]